Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Careful planning and technique are crucial for successful hair transplants on irradiated scalps.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Good medication adherence improves quality of life in subclinical thyroid disorder patients.

Promising cancer treatments were found, but the manufacturer closed.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

The new assay can help develop products for hair re-growth.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Thyroid hormone (T3) may reverse gray hair by stimulating hair growth.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Strontium ranelate is no longer available for treatment.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Soy isoflavones can protect lung tissue from radiation damage.

AHR ligands could treat inflammatory skin diseases.

Thyroid hormone receptors are essential for hair growth and wound healing.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

The new drug delivery system effectively targets lung cancer cells.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.